Valera Pharmaceuticals (originally Hydro Med Sciences) was founded in 1972 and is credited with the development of soft contact lenses which were sold to Allergan in 1987. The company completed a $7 million private placement of a Series A Convertible Preferred Stock in January 2002. Until this point, Hydro Med Sciences had been a wholly owned subsidiary of GP Strategies. Hydro Med Sciences changed its name to Valera Pharmaceuticals in September 2003. Today, Valera Pharmaceuticals focuses on specialty drug delivery with its unique hydrogel-based Hydron technology.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Valera Pharmaceuticals
7 Clarke Drive
Cranbury
New Jersey
08512 New Jersey
All rights reserved. Terms and Conditions | Contact us
